MedTrace Logo

Tear Lipid Layer Thickness With Emollient Eye Drops

NCT03380624 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-02-03

Study results available
· View outcomes & findings →

Summary

Crossover comparison of lipid layer thickness with two artificial tear formulations

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

Refresh Optive

Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose

DRUG

Refresh Optive MEGA-3

Lubricate and hydrating relief of eye dryness investigational lubricant eye drop is based on carboxymethylcellulose and with flaxseed oil and trehalose

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Ohio State University

    lead OTHER

Principal Investigators

  • Jennifer Fogt, OD MS · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-06-30
Completion
2018-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380624 on ClinicalTrials.gov